News & Updates

Alcohol consumption contributes to increased mortality and major adverse cardiovascular events (MACE) among US veterans, with a J-shaped association indicating reduced risk at moderate consumption levels compared with abstinence of heavier drinking, suggests a study.

Cutting thickened or retracted secondary chordae of the anterior mitral leaflet related to septal myectomy demonstrates positive long-term clinical and haemodynamic results in patients with hypertrophic cardiomyopathy (HCM), a study has shown.

Use of antithrombotic agents at admission does not increase the risk of in-hospital mortality in patients with acute upper gastrointestinal bleeding (UGIB), according to a study, noting a protective trend overall and significant protection in antiplatelet users and nonvariceal bleeding.

A pooled analysis of data from five studies shows that a shorter time-restricted eating (TRE) window leads to greater weight loss.

Mechanistic insights into how the left atrium (LA) adapts to progressive diastolic dysfunction in patients with hypertrophic cardiomyopathy (HCM) can be gleaned through a proposed physiological LA staging framework, which is associated with a graded risk of new-onset atrial fibrillation (AF) and potentially useful in creating AF surveillance strategies, suggests a study.

New drug applications approved by US FDA as of 16-31 October 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

In patients with kidney failure who are undergoing haemodialysis, initiating treatment with apixaban soon after a diagnosis of atrial fibrillation (AF) is associated with lower risks of ischaemic stroke and clinically important bleeding compared with warfarin, according to a study.